This issue presents the use of PET imaging in the diagnosis, staging, and follow up of melanoma. Differentiation of early versus advanced stages of melanomaare reviewed in separate articles. As with other forms of cancer, assessing response to treatment is essential as well monitoring for recurrence. The issue also provides a glimpse into the future through a review of newer radionuclide tracers currently in development.